It seems like a lifetime since we first became aware of COVID-19. In the early days of the pandemic, there was some talk about the possibility of a vaccine, but it all seemed very remote. Now, less than a year later, there are no less than thirty-eight different candidate vaccines at various stages of development, and at least five of those are already being used in various jurisdictions. The focus has shifted from “when?” to “what?” and “how?”